ÂÜÀòÂÒÂ×

Alberto Auricchio serves as the Scientific Director and Principal Investigator at Tigem since September 2002 and has been the Coordinator of the Molecular Therapy programme. Within the academic sector, Alberto Auricchio holds multiple roles at the University of Naples Federico II, including Faculty Lecturer in Medical Genetics and Full Professor of Medical Genetics in the Department of Advanced Biomedical Sciences. Additionally, Alberto Auricchio is the Vice President of the European Society of Gene and Cell Therapy and has contributed to various positions, including Founder and Chief Scientific Officer at AAVantgarde Bio, and Founder and Consultant at InnovaVector. The educational background includes extensive training at the University of Pennsylvania, culminating in several postdoctoral degrees, and prior medical training at Università degli Studi di Napoli Federico II and Università degli Studi di Milano.